Marco Bustamante-Balen
Overview
Explore the profile of Marco Bustamante-Balen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
278
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Argumanez V, Plume G, Bustamante-Balen M
Gastroenterol Hepatol
. 2024 Nov;
:502286.
PMID: 39549819
Patients undergoing colonoscopy are increasingly taking antithrombotic medication. These patients, who are generally older, also have a higher prevalence of colon polyps. Therefore, it is general practice to modify or...
2.
Argumanez V, Lorenzo-Zuniga V, Bustamante-Balen M, Garcia Garcia S, Terol Chafer I, Oltra S, et al.
Gastroenterol Hepatol
. 2024 Oct;
PMID: 39395692
Introduction: Familial adenomatous polyposis (FAP) is a hereditary disease caused by mutations in the APC gene, which is also associated with extracolonic manifestations. The objective was to characterize the extracolonic...
3.
Medina-Prado L, Sala-Miquel N, Aicart-Ramos M, Lopez-Cardona J, Ponce-Romero M, Ortiz O, et al.
Cancer Med
. 2024 Mar;
13(5):e6923.
PMID: 38491824
Background And Study Aims: Our aim was to determine the impact of the SARS-CoV-2 pandemic on the diagnosis and prognosis of colorectal cancer (CRC). Patients And Methods: This prospective cohort...
4.
Soutullo-Castineiras C, Bustamante-Balen M
Transl Cancer Res
. 2023 Oct;
12(9):2429-2432.
PMID: 37859731
No abstract available.
5.
Safont M, Garcia-Figueiras R, Hernando-Requejo O, Jimenez-Rodriguez R, Lopez-Vicente J, Machado I, et al.
Clin Transl Oncol
. 2023 Oct;
26(4):825-835.
PMID: 37787973
Watch-and-wait has emerged as a new strategy for the management of rectal cancer when a complete clinical response is achieved after neoadjuvant therapy. In an attempt to standardize this new...
6.
Argumanez Tello V, Sanchez-Montes C, Minguez Sabater A, Bauza M, Bustamante-Balen M
Rev Esp Enferm Dig
. 2023 Mar;
115(12):732-733.
PMID: 36926922
Endoscopic findings in primary or secondary intestinal lymphoma are non-specific, which can lead to finding a polyp, an ulcer or a completely normal mucosa. As a matter of fact, this...
7.
Bustamante-Balen M
World J Gastroenterol
. 2023 Jan;
28(47):6619-6631.
PMID: 36620344
Implementing population-based screening programs for colorectal cancer has led to an increase in the detection of large but benign histological lesions. Currently, endoscopic mucosal resection can be considered the standard...
8.
Lopez-Munoz P, Garcia-Campos M, Lorenzo-Zuniga V, Alonso-Lazaro N, Arguello L, Bustamante-Balen M, et al.
Dig Dis Sci
. 2022 Sep;
68(2):339-340.
PMID: 36156753
No abstract available.
9.
Bustamante-Balen M, Garcia-Campos M, Lorenzo-Zuniga V, Alonso-Lazaro N, Sanchez-Montes C, Arguello-Viudez L, et al.
Endosc Int Open
. 2022 Sep;
10(9):E1238-E1244.
PMID: 36118644
In contrast with the European Society of Gastrointestinal Endoscopy (ESGE) 2013 and the US Multi-society Task Force (USMSTF) 2020 guidelines, the ESGE 2020 guideline considers patients with three to four...
10.
Sancho-Muriel J, Pellino G, Cholewa H, Giner F, Bustamante-Balen M, Montesarchio L, et al.
Cir Esp (Engl Ed)
. 2022 Sep;
100(10):635-640.
PMID: 36109115
Introduction: Endoscopic resection offers advantages over surgical resection for early colorectal cancer (ECC). However, there might be a presumed risk of recurrence. We aimed to determine the risk of recurrence...